Orla Protein Technologies is a biotechnology startup that specializes in creating and engineering recombinant proteins for advanced surface applications in the Life Sciences. Their proprietary OrlaSURF technology enables the formation of highly oriented and functional protein surfaces, which find diverse commercial applications in bioanalytical devices, cell culture, bioseparations, and assay development. Founded in 2002, the company received a significant £500.00K Angel Round investment on 21 June 2013 to further support its innovative protein solutions. Although the headquarters information is not available, Orla Protein Technologies stands poised to continue making strides in the biotechnology industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Angel Round | £500.00K | - | 21 Jun 2013 |
No recent news or press coverage available for Orla Protein Technologies.